ARKG Investment Tracker position change: Increased position in GeneDx Holdings by 2,232 shares, the number of shares held increased 2.15% compared to the previous period and now represents 0.98% of the total position.
ARKG Investment Tracker position change: Increased position in Regeneron Pharmaceuticals by 252 shares, the number of shares held increased 2.07% compared to the previous period and now represents 0.55% of the total position.
ARKG Investment Tracker position change: Increased position in Pacific Biosciences of California by 233,280 shares, the number of shares held increased 2.16% compared to the previous period and now represents 1.38% of the total position.
ARKG Investment Tracker position change: Increased position in Veeva by 864 shares, the number of shares held increased 2.11% compared to the previous period and now represents 0.9% of the total position.
ARKG Investment Tracker position change: Decreased position in Natera by 1,063 shares, the number of shares held decreased 0.38% compared to the previous period and now represents 3.9% of the total position.
ARKG Investment Tracker position change: Increased position in Beam Therapeutics, Inc. by 42,264 shares, the number of shares held increased 2.15% compared to the previous period and now represents 3.97% of the total position.
ARKG Investment Tracker position change: Increased position in ATAI Life Sciences B.V.* by 774,961 shares, the number of shares held increased 33.62% compared to the previous period and now represents 1.51% of the total position.
ARKG Investment Tracker position change: Increased position in Amgen by 1,026 shares, the number of shares held increased 2.15% compared to the previous period and now represents 1.11% of the total position.
ARKG Investment Tracker position change: Increased position in Exact Sciences by 5,346 shares, the number of shares held increased 2.15% compared to the previous period and now represents 1.19% of the total position.
ARKG Investment Tracker position change: Increased position in Ionis Pharmaceuticals by 13,752 shares, the number of shares held increased 2.15% compared to the previous period and now represents 3.64% of the total position.